Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
出版年份 2021 全文链接
标题
Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
作者
关键词
-
出版物
CRITICAL REVIEWS IN TOXICOLOGY
Volume -, Issue -, Pages 1-24
出版商
Informa UK Limited
发表日期
2021-04-16
DOI
10.1080/10408444.2021.1888073
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells
- (2020) Anne-Cathrin Behr et al. ARCHIVES OF TOXICOLOGY
- Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
- (2020) Ying Li et al. Environmental Health
- Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells
- (2020) Jochem Louisse et al. ARCHIVES OF TOXICOLOGY
- Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region
- (2020) Cristina Canova et al. ENVIRONMENT INTERNATIONAL
- Dose effects of ammonium perfluorooctanoate on lipoprotein metabolism in APOE*3-Leiden.CETP mice
- (2019) Marianne G Pouwer et al. TOXICOLOGICAL SCIENCES
- Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: Isomers of C8 Health Project in China
- (2019) Min Nian et al. ENVIRONMENTAL RESEARCH
- System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells
- (2019) Leonore Wigger et al. PLoS One
- Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria
- (2019) Daniella M. Pizzurro et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases
- (2019) Matthew M Yeh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Identifying qualitative differences in PPARα signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods
- (2019) Patrick D. McMullen et al. TOXICOLOGY IN VITRO
- Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration
- (2019) Anika L. Dzierlenga et al. XENOBIOTICA
- Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice
- (2019) Marianne G. Pouwer et al. JOURNAL OF LIPID RESEARCH
- Activation of human nuclear receptors by perfluoroalkylated substances (PFAS)
- (2019) Anne-Cathrin Behr et al. TOXICOLOGY IN VITRO
- The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice
- (2018) Montserrat A. de la Rosa Rodriguez et al. BMC GENOMICS
- Changes in markers of liver function in relation to changes in perfluoroalkyl substances - A longitudinal study
- (2018) Samira Salihovic et al. ENVIRONMENT INTERNATIONAL
- Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives
- (2018) Melissa I. Gomis et al. ENVIRONMENT INTERNATIONAL
- FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
- (2018) Romeo Papazyan et al. JOURNAL OF LIPID RESEARCH
- Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)
- (2018) Matteo Convertino et al. TOXICOLOGICAL SCIENCES
- Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol
- (2018) Leandro R. Marques et al. Frontiers in Physiology
- Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment
- (2018) Harm J. Heusinkveld et al. FOOD AND CHEMICAL TOXICOLOGY
- Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species
- (2018) Zied Kaabia et al. Scientific Reports
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- (2018) Pratik B Sandesara et al. ENDOCRINE REVIEWS
- Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers
- (2018) Ram B. Jain et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies
- (2017) Virginia Ballesteros et al. ENVIRONMENT INTERNATIONAL
- Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice
- (2017) Xinmou Wu et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- The impact of exposure to environmental contaminant on hepatocellular lipid metabolism
- (2017) Zongguang Hui et al. GENE
- Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells
- (2017) Anna Kjerstine Rosenmai et al. JOURNAL OF APPLIED TOXICOLOGY
- Poly- and perfluorinated compounds activate human pregnane X receptor
- (2017) Yi-Ming Zhang et al. TOXICOLOGY
- Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis
- (2017) Kaberi P. Das et al. TOXICOLOGY
- PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
- (2017) Mitchell B. Rosen et al. TOXICOLOGY
- Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid
- (2016) Taiki Abe et al. ARCHIVES OF TOXICOLOGY
- HDL functionality in reverse cholesterol transport — Challenges in translating data emerging from mouse models to human disease
- (2016) Miriam Lee-Rueckert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats
- (2016) Sook-Jin Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory
- (2016) Elizabeth C. Leritz et al. METABOLIC BRAIN DISEASE
- The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction
- (2016) Kevin M. Beggs et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Crosstalk of HNF4 α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids
- (2016) Hong Lu Acta Pharmaceutica Sinica B
- The impact of PPARα activation on whole genome gene expression in human precision cut liver slices
- (2015) Aafke W.F. Janssen et al. BMC GENOMICS
- Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007–2010
- (2015) Jessie A. Gleason et al. ENVIRONMENTAL RESEARCH
- Isomer-Specific Binding Affinity of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) to Serum Proteins
- (2015) Sanjay Beesoon et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
- (2015) Susan Kühnast et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Toxicokinetics of perfluoroalkyl carboxylic acids with different carbon chain lengths in mice and humans
- (2015) Yukiko Fujii et al. JOURNAL OF OCCUPATIONAL HEALTH
- Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats
- (2015) Wen Zhao et al. TOXICOLOGICAL SCIENCES
- Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes
- (2015) Thorsten Buhrke et al. TOXICOLOGY
- Deciphering the roles of the constitutive androstane receptor in energy metabolism
- (2014) Jiong Yan et al. ACTA PHARMACOLOGICA SINICA
- Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days
- (2014) Shengmin Yan et al. ARCHIVES OF TOXICOLOGY
- Cholesterol and Lipoprotein Metabolism
- (2014) Hanrui Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts
- (2014) Andrea Winquist et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Toxicokinetics of Seven Perfluoroalkyl Sulfonic and Carboxylic Acids in Pigs Fed a Contaminated Diet
- (2014) Jorge Numata et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
- (2014) Brandon Ason et al. JOURNAL OF LIPID RESEARCH
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- High Fat Diet Feeding Exaggerates Perfluorooctanoic Acid-Induced Liver Injury in Mice via Modulating Multiple Metabolic Pathways
- (2014) Xiaobing Tan et al. PLoS One
- Cross-Species Gene Expression Analysis of Species Specific Differences in the Preclinical Assessment of Pharmaceutical Compounds
- (2014) John Okyere et al. PLoS One
- Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation
- (2014) Cynthia J. Wolf et al. TOXICOLOGY
- PBPK modeling for PFOS and PFOA: Validation with human experimental data
- (2014) Francesc Fàbrega et al. TOXICOLOGY LETTERS
- PFOS induced lipid metabolism disturbances in BALB/c mice through inhibition of low density lipoproteins excretion
- (2014) Ling Wang et al. Scientific Reports
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- The association between PFOA, PFOS and serum lipid levels in adolescents
- (2013) Sarah Dee Geiger et al. CHEMOSPHERE
- Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study
- (2013) J. Christopher Corton et al. CRITICAL REVIEWS IN TOXICOLOGY
- Accumulation of perfluoroalkyl substances in human tissues
- (2013) Francisca Pérez et al. ENVIRONMENT INTERNATIONAL
- Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
- (2013) Anne P. Starling et al. ENVIRONMENT INTERNATIONAL
- Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonate Concentrations in Relation to Birth Outcomes in the Mid-Ohio Valley, 2005–2010
- (2013) Lyndsey A. Darrow et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid
- (2013) Nicola Fitz-Simon et al. EPIDEMIOLOGY
- Cholesteryl ester transfer proteins from different species do not have equivalent activities
- (2013) Richard E. Morton et al. JOURNAL OF LIPID RESEARCH
- An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid
- (2013) Siyuan Peng et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population
- (2013) Kirsten T. Eriksen et al. PLoS One
- Mice with Chimeric Livers Are an Improved Model for Human Lipoprotein Metabolism
- (2013) Ewa C. S. Ellis et al. PLoS One
- Specific Accumulation of Lipid Droplets in Hepatocyte Nuclei of PFOA-exposed BALB/c Mice
- (2013) Ling Wang et al. Scientific Reports
- PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport
- (2012) H.T. Wan et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Low-Density Lipoprotein Cholesterol, Apolipoprotein B, and Risk of Coronary Heart Disease: From Familial Hyperlipidemia to Genomics
- (2012) C. C. Imes et al. Biological Research for Nursing
- Expanding Roles for SREBP in Metabolism
- (2012) Wei Shao et al. Cell Metabolism
- PPARα/HNF4α Interplay on Diversified Responsive Elements. Relevance in the Regulation of Liver Peroxisomal Fatty Acid Catabolism
- (2012) Julie Chamouton et al. CURRENT DRUG METABOLISM
- Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure
- (2012) Valentina Gallo et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Nuclear Receptors HNF4α and LRH-1 Cooperate in RegulatingCyp7a1 in Vivo
- (2012) Serkan Kir et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats
- (2012) John L. Butenhoff et al. TOXICOLOGY
- Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats
- (2012) John L. Butenhoff et al. TOXICOLOGY
- Hepatocellular hypertrophy and cell proliferation in Sprague–Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
- (2012) Clifford R. Elcombe et al. TOXICOLOGY
- Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4α)
- (2012) E. Scharmach et al. TOXICOLOGY LETTERS
- Modulation of ammonium perfluorooctanoate-induced hepatic damage by genetically different PPARα in mice
- (2011) Tomohiko Nakagawa et al. ARCHIVES OF TOXICOLOGY
- Renal Elimination of Perfluorocarboxylates (PFCAs)
- (2011) Xing Han et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis
- (2011) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys
- (2011) Shu-Ching Chang et al. REPRODUCTIVE TOXICOLOGY
- Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): Further investigation of C4–C12 compounds
- (2011) Cynthia J. Wolf et al. REPRODUCTIVE TOXICOLOGY
- Perfluoroalkyl Sulfonates Cause Alkyl Chain Length–Dependent Hepatic Steatosis and Hypolipidemia Mainly by Impairing Lipoprotein Production in APOE*3-Leiden CETP Mice
- (2011) Silvia Bijland et al. TOXICOLOGICAL SCIENCES
- Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
- (2011) J.A. Bjork et al. TOXICOLOGY
- SREBPs: metabolic integrators in physiology and metabolism
- (2011) Tae-Il Jeon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Perfluorooctanoic Acid, Perfluorooctanesulfonate, and Serum Lipids in Children and Adolescents
- (2010) Stephanie J. Frisbee et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Hepatic Hepatocyte Nuclear Factor 4α Is Essential for Maintaining Triglyceride and Cholesterol Homeostasis
- (2010) Liya Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of Peroxisome Proliferator-activated Receptor-α in Hepatobiliary Injury Induced by Ammonium Perfluorooctanoate in Mouse Liver
- (2010) Mutsuko MINATA et al. INDUSTRIAL HEALTH
- Two-year follow-up biomonitoring pilot study of residents’ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany
- (2010) Edna Brede et al. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
- (2010) Elisa Fabbrini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Human detoxification of perfluorinated compounds
- (2010) S.J. Genuis et al. PUBLIC HEALTH
- Gene Expression Profiling in Wild-Type and PPAR-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR-Independent Effects
- (2010) Mitchell B. Rosen et al. PPAR Research
- Association of Perfluorooctanoic Acid and Perfluorooctane Sulfonate With Serum Lipids Among Adults Living Near a Chemical Plant
- (2009) K. Steenland et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Investigation of the Associations Between Low-Dose Serum Perfluorinated Chemicals and Liver Enzymes in US Adults
- (2009) Chien-Yu Lin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Human Organic Anion Transporter hOAT4 is a Transporter of Perfluorooctanoic Acid
- (2009) Hatsuki Nakagawa et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia
- (2009) Scott M. Bartell et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population
- (2009) Jessica W. Nelson et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
- (2009) M. J. Chapman et al. EUROPEAN HEART JOURNAL
- Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species
- (2009) Hongzu Ren et al. REPRODUCTIVE TOXICOLOGY
- Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid–Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell Cultures
- (2009) James A. Bjork et al. TOXICOLOGICAL SCIENCES
- Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor α, but not human PPARα
- (2009) Toshiki Nakamura et al. TOXICOLOGY
- Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats
- (2009) Ching-Hui Yang et al. TOXICOLOGY LETTERS
- Regulation of Bile Acid and Cholesterol Metabolism by PPARs
- (2009) Tiangang Li et al. PPAR Research
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase
- (2008) Russell A DeBose-Boyd CELL RESEARCH
- Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha
- (2008) Jamie C. DeWitt et al. CRITICAL REVIEWS IN TOXICOLOGY
- EFFECTS OF PERFLUOROOCTANE SULFONATE ON RAT THYROID HORMONE BIOSYNTHESIS AND METABOLISM
- (2008) Wen-Guang Yu et al. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
- Altered Fatty Acid Homeostasis and Related Toxicologic Sequelae in Rats Exposed to Dietary Potassium Perfluorooctanesulfonate (PFOS)
- (2008) Ivan Curran et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- Gene Profiling in the Livers of Wild-type and PPARα-Null Mice Exposed to Perfluorooctanoic Acid
- (2008) Mitchell B. Rosen et al. TOXICOLOGIC PATHOLOGY
- Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPARα and CAR
- (2008) Mitchell B. Rosen et al. TOXICOLOGICAL SCIENCES
- Activation of Mouse and Human Peroxisome Proliferator−Activated Receptor Alpha by Perfluoroalkyl Acids of Different Functional Groups and Chain Lengths
- (2008) Cynthia J. Wolf et al. TOXICOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started